- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06170333
8% Sulphur-Aloe Vera Soap as an Adjuvant Treatment for Pityriasis Versicolor
Efficacy and Side Effects of 8% Sulphur-Aloe Vera Soap Versus Bland Soap as an Adjuvant of Ketoconazole 2% Shampoo for the Treatment of Pityriasis Versicolor: Open Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Contact
- Name: Risa Miliawati Nurul Hidayah, MD, Ph.D
- Phone Number: +628122324231
- Email: risa.kulkel@yahoo.com
Study Contact Backup
- Name: Nadia Octavia, MD
- Phone Number: +628112399890
- Email: nadia.octavia@gmail.com
Study Locations
-
-
Jawa Barat
-
Bandung, Jawa Barat, Indonesia, 40161
- Hasan Sadikin General Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Male or female
- Age 18-65 years
- Diagnosed as PV based on clinical features, microscopic examination using 10% potassium hydroxide, and Wood's lamp
Exclusion Criteria:
- Pregnant or lactating women
- PV with concurrent skin conditions (dermatitis or skin lesions in form of vesicles or blister or pustules or erosions or excoriation) with body surface area >30%
- Use of topical antifungal and/or corticosteroid 14 days prior to study entry
- Use of systemic antifungal and/or corticosteroid 30 days prior to study entry
- History of allergy to shampoo or soap containing ketoconazole, sodium lauryl sulphate, sulphur, A. vera, charcoal powder, glycerin, or perfume.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 8% sulphur and A. vera soap and ketoconazole 2% shampoo
Twenty-one patients will be given the combination of 8% sulphur and A. vera soap applied to the entire body surface (excluding face), left on for five minutes and then washed off. This was applied twice daily for four weeks. Along with the soap or placebo, patients will receive 2% ketoconazole shampoo, left on for five minutes and then washed off. This was applied thrice weekly for a week |
Patients in experimental arms will receive the combination of 8% sulphur and A. vera soap for four weeks along with 2% ketoconazole shampoo for a week.
Other Names:
|
Active Comparator: Bland soap and ketoconazole 2% shampoo
Twenty-one patients will be given bland soap applied to the entire body surface (excluding face), left on for five minutes and then washed off. This was applied twice daily for four weeks. Along with the soap or placebo, patients will receive 2% ketoconazole shampoo, left on for five minutes and then washed off. This was applied thrice weekly for a week. |
Patients in experimental arms will receive the combination of 8% sulphur and A. vera soap for four weeks along with 2% ketoconazole shampoo for a week.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Clinical assessment of pruritus
Time Frame: 28 days
|
A visual analogue score (VAS) will be used to assess pruritus according to the following scale: 0 = no pruritus; 1-3 = mild pruritus; 4-6 = moderate pruritus; 7-10 = severe pruritus.
|
28 days
|
Scaling severity
Time Frame: 28 days
|
Patients will be evaluated for scaling severity according to the following scale: 0 = no scaling; 1 = mild distribution of scaling; 2 = moderate distribution of scaling; 3 = severe, extensive distribution of scaling.
|
28 days
|
Mycological cure
Time Frame: 28 days
|
Evaluation of mycological cure examined by microscopic examination using 10% potassium hydroxide.
A cellophane tape will be used for taking scale lesions.
|
28 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Wood's lamp
Time Frame: 28 days
|
Fluorescence of skin lesions using Wood's lamp will be evaluated every visit.
Positive result obtained if skin lesions showed yellow fluorescence.
|
28 days
|
Skin hydration
Time Frame: 28 days
|
Skin hydration will be measured using corneometer on three areas: volar, wrist, and palms.
Scores are expressed in arbitary units (AU), AU <30 means very dry skin, AU between 30 -40 means dry skin, and AU >40 means normal skin
|
28 days
|
Skin pH (potential hydrogen)
Time Frame: 28 days
|
Skin pH will be measured using pH on three areas: volar, wrist, and palms.
Normal skin pH values range from pH 4.0 to 7.0.
pH level below 7 considered acidic and above 7 considered alkaline.
|
28 days
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Risa Miliawati Nurul Hidayah, MD, Ph.D, Faculty of Medicine, Universitas Padjadjaran, Bandung
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DV-202309.02
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pityriasis Versicolor
-
Kasr El Aini HospitalRecruiting
-
Kasr El Aini HospitalRecruiting
-
Indonesia UniversityCompleted
-
Combined Military Hospital AbbottabadCompleted
-
Mayo ClinicCompletedPITYRIASIS RUBRA PILARISUnited States
-
Universidad Autonoma de San Luis PotosíHospital Central "Dr. Ignacio Morones Prieto"Completed
-
Joshua ZeichnerAstellas Pharma IncTerminatedPityriasis Rubra PilarisUnited States
-
Research Institute of Epidemiology, Microbiology...Active, not recruitingPityriasis AlbaUzbekistan
-
St Joseph University, Beirut, LebanonUnknown
-
Oregon Health and Science UniversityActive, not recruitingPityriasis Rubra PilarisUnited States
Clinical Trials on 8% sulphur and A. vera soap
-
Academisch Medisch Centrum - Universiteit van Amsterdam...TerminatedProstate CancerNetherlands
-
University Hospital, RouenNot yet recruiting
-
Suzhou Zanrong Pharma LimitedRecruitingAdvanced Solid Tumors | HER2-positive Breast CancerChina
-
McGill UniversityCanadian Institutes of Health Research (CIHR); McMaster University; Drexel UniversityNot yet recruitingCerebral Palsy | Amputation | Spinal Cord Injuries | Spina Bifida | Musculoskeletal Disorder | Juvenile ArthritisCanada
-
PfizerCompleted
-
University of Campania "Luigi Vanvitelli"Federico II UniversityCompleted
-
Brown UniversityThe Miriam Hospital; Rhode Island HospitalCompletedProstate CancerUnited States
-
IrsiCaixaHospital Clinic of Barcelona; University of Oxford; Fundación FLS de Lucha Contra... and other collaboratorsCompleted
-
Guang'anmen Hospital of China Academy of Chinese...UnknownType 2 Diabetes Mellitus ;Obesity,High Triglycerides;TCMChina
-
University Hospital of CreteCompletedNon Small Cell Lung Cancer | MetastaticGreece